Patents Assigned to Tianjin University of Science and Technology
-
Publication number: 20240025756Abstract: The disclosure discloses a method for producing ?-calcium sulfate hemihydrate whiskers by using fermentation broth for producing lactic acid with a calcium salt method as a raw material and synchronously recovering a lactic acid monomer. The method comprises the following steps: 1) after fermentation of lactic acid is ended, heating fermentation broth; 2) stirring, and adding sulfuric acid for reaction; 3) after the reaction is ended, filtering and collecting a solid part, namely ?-calcium sulfite hemihydrate whiskers, and collecting a liquid part, namely a free lactic acid solution containing the lactic acid monomer; and 4) washing and drying the obtained ?-calcium sulfate hemihydrate whiskers to obtain a ?-calcium sulfate hemihydrate whisker finished product, filtering and concentrating the obtained free lactic acid solution to obtain a lactic acid crude product, and refining the lactic acid crude product to obtain a high-purity lactic acid monomer.Type: ApplicationFiled: February 3, 2021Publication date: January 25, 2024Applicant: TIANJIN UNIVERSITY OF SCIENCE & TECHNOLOGYInventors: Zhengxiang WANG, Dandan NIU, Kangming TIAN, Fuping LU, Chunli SHEN
-
Patent number: 11866737Abstract: The invention relates to a 2-isopropyl malate synthase, a genetically engineered bacterium for producing L-leucine and application thereof and belongs to the field of metabolic engineering. The genetically engineered bacterium is obtained by overexpressing an isopropyl malate synthase coding gene leuAM for relieving feedback inhibition by L-leucine, an acetohydroxy acid synthase coding gene ilvBNM for relieving feedback inhibition by L-isoleucine, a 3-isopropyl malate dehydrogenase coding gene leuB and a 3-isopropyl malate dehydratase coding gene leuCD in host cells. The genetically engineered bacterium for producing the L-leucine is free from nutritional deficiency, rapid in growth, short in fermentation period, high in yield and high in conversion rate.Type: GrantFiled: December 29, 2020Date of Patent: January 9, 2024Assignee: Tianjin University of Science and TechnologyInventors: Chenglin Zhang, Qingyang Xu, Yanjun Li, Yu Zhang, Yingzi Li, Fuzhou Zhu, Nan Lu, Shibao Han, Xierong Dong, Zishen Wang, Hao Xu, Ziyi Li
-
Patent number: 11802300Abstract: A genetically engineered strain having high-yield of L-valine is disclosed. Starting from Escherichia coli W3110, an acetolactate synthase gene alsS of Bacillus subtilis is inserted into a genome thereof and overexpressed; a ppGpp 3?-pyrophosphate hydrolase mutant R290E/K292D gene spoTM of Escherichia coli is inserted into the genome and overexpressed; a lactate dehydrogenase gene ldhA, a pyruvate formate lyase I gene pflB, and genes frdA, frdB, frdC, frdD of four subunits of fumaric acid reductase are deleted from the genome; a leucine dehydrogenase gene bcd of Bacillus subtilis replaces a branched chain amino acid transaminase gene ilvE of Escherichia coli; and an acetohydroxy acid isomeroreductase mutant L67E/R68F/K75E gene ilvCM replaces the native acetohydroxy acid isomeroreductase gene ilvC of Escherichia coli. Furthermore, the L-valine fermentation method is improved by using a two-stage dissolved oxygen control. The L-valine titer and the sugar-acid conversion rate are increased.Type: GrantFiled: October 30, 2019Date of Patent: October 31, 2023Assignee: TIANJIN UNIVERSITY OF SCIENCE & TECHNOLOGYInventors: Xixian Xie, Heyun Wu, Jiachu Wang, Faqing Wu, Xiaoqian Liu, Yanan Hao
-
Patent number: 11753615Abstract: The present disclosure belongs to the field of bioengineering, and relates to breeding of industrial microorganisms, in particular to a genetically engineered strain of Saccharomyces cerevisiae, method for constructing the same, and its use for brewing, the genetically engineered strain of Saccharomyces cerevisiae heterogeneously overexpresses an acetaldehyde dehydrogenase gene ALD6, an acetyl-CoA synthase gene ACS1 and an alcohol acyltransferase gene AeAT9. The Saccharomyces cerevisiae strain with high yield of ethyl acetate and low yield of higher alcohols provided by the present disclosure not only maintains excellent ethanol fermentation characteristics, but also reducing the production of higher alcohols which adversely affect the comfort after drinking, which is of great significance for a well-maintained and strengthened flavor characteristics of Chinese Baijiu, an improved and stabilized quality thereof, and even a reform in the fermentation process thereof.Type: GrantFiled: August 25, 2021Date of Patent: September 12, 2023Assignee: Tianjin University of Science and TechnologyInventors: Yefu Chen, Wenqi Shi, Guo Zhang, Ruirui Li, Yanfang Chen, Huan Wang, Chunhong Sun, Dongguang Xiao, Xiaole Wu, Xuewu Guo
-
Patent number: 11746353Abstract: A Saccharomyces cerevisiae strain with high yield of ethyl butyrate and a construction method and an application thereof are provided. The strain is obtained by over-expressing in the starting strain acetyl coenzyme A acyl transferase gene Erg10, 3-hydroxybutyryl coenzyme A dehydrogenase gene Hbd, 3-hydroxybutyryl coenzyme A dehydratase gene Crt, trans-2-enoyl coenzyme A reductase gene Ter, and alcohol acyl transferase gene AAT. Compared to the starting bacteria not producing ethyl butyrate, the yield of ethyl butyrate of the constructed strain reaches 77.33±3.79 mg/L, the yield of the ethyl butyrate of the strain with double copy expression of gene Ter and gene AAT reaches 99.65±7.32 mg/L, increased by 28.9% compared with the EST strain, and 40.93±3.18 mg/L of ethyl crotonate is unexpectedly produced.Type: GrantFiled: December 25, 2020Date of Patent: September 5, 2023Assignee: Tianjin University of Science and TechnologyInventors: Yefu Chen, Yanrui Ma, Yongjing Du, Sen Jiang, Jinying Ren, Guo Zhang, Xinyue Kang, Peng Zheng, Xiaole Wu, Dongguang Xiao, Xuewu Guo
-
Patent number: 11692178Abstract: A genetically engineered bacterium includes a genome of the Eschericia coli and a mutant encoding gene hisG* of a Corynebacterium glutamicum ATP phosphoribosyl transferase HisG on the genome, and the gene hisG* is strongly expressed to enhance activity of a key enzyme HisG for histidine synthesis. The gene hisG* has a nucleotide sequence as shown in SEQ ID NO: 1; a copy number of histidine operon genes hisDBCHAFI of the Eschericia coli is further increased on the genome to enhance a terminal synthetic route of histidine; an encoding gene lysE from an arginine/lysine transportprotein of the Corynebacterium glutamicum is further integrated to the genome and strongly expressed to promote the intracellular histidine secrete to the extracellular space; and an encoding gene rocG of glutamate dehydrogenase of Bacillus subtilis is further integrated to the genome and strongly expressed to promote generation of histidine.Type: GrantFiled: June 18, 2021Date of Patent: July 4, 2023Assignees: ZHEJIANG ZHENYUAN BIOTECH CO., LTD., Tianjin University of Science and TechnologyInventors: Xixian Xie, Weiming Fan, Heyun Wu, Wei Jiang, Daoguang Tian, Yanna Chen, Yue Zhang, Jianqing Tu
-
Patent number: 11655464Abstract: An alkaline protease mutant, and a gene, engineered strain, a preparation method and application thereof are provided. The method comprises the following steps of extracting genome DNA of Bacillus clausii, performing PCR amplification to obtain a wild-type alkaline protease gene sequence, mutating the wild-type alkaline protease gene obtained by the amplification through an error-prone PCR, performing high-throughput screening to obtain a plurality of highly active alkaline protease genes, performing DNA shuffling on the highly active alkaline protease genes, and performing screening to obtain eight alkaline protease mutant genes with higher activity.Type: GrantFiled: July 31, 2022Date of Patent: May 23, 2023Assignees: Tianjin University of Science and Technology, Shandong Lonct Enzymes Co. LTDInventors: Fuping Lu, Yihan Liu, Yu Li, Xingji Wang, Kefen Wang, Wenlong Liu, Fufeng Liu, Huitu Zhang
-
Publication number: 20230107828Abstract: A genetically engineered strain having high-yield of L-valine is disclosed. Starting from Escherichia coli W3110, an acetolactate synthase gene alsS of Bacillus subtilis is inserted into a genome thereof and overexpressed; a ppGpp 3?-pyrophosphate hydrolase mutant R290E/K292D gene spoTM of Escherichia coli is inserted into the genome and overexpressed; a lactate dehydrogenase gene ldhA, a pyruvate formate lyase I gene pflB, and genes frdA, frdB, frdC, frdD of four subunits of fumaric acid reductase are deleted from the genome; a leucine dehydrogenase gene bcd of Bacillus subtilis replaces a branched chain amino acid transaminase gene ilvE of Escherichia coli; and an acetohydroxy acid isomeroreductase mutant L67E/R68F/K75E gene ilvCM replaces the native acetohydroxy acid isomeroreductase gene ilvC of Escherichia coli. Furthermore, the L-valine fermentation method is improved by using a two-stage dissolved oxygen control. The L-valine titer and the sugar-acid conversion rate are increased.Type: ApplicationFiled: October 30, 2019Publication date: April 6, 2023Applicant: TIANJIN UNIVERSITY OF SCIENCE & TECHNOLOGYInventors: Xixian XIE, Heyun WU, Jiachu WANG, Faqing WU, Xiaoqian LIU, Yanan HAO
-
Publication number: 20230016224Abstract: An alkaline protease mutant, and a gene, engineered strain, a preparation method and application thereof are provided. The method comprises the following steps of extracting genome DNA of Bacillus clausii, performing PCR amplification to obtain a wild-type alkaline protease gene sequence, mutating the wild-type alkaline protease gene obtained by the amplification through an error-prone PCR, performing high-throughput screening to obtain a plurality of highly active alkaline protease genes, performing DNA shuffling on the highly active alkaline protease genes, and performing screening to obtain eight alkaline protease mutant genes with higher activity.Type: ApplicationFiled: July 31, 2022Publication date: January 19, 2023Applicants: Tianjin University of Science and Technology, Shandong Lonct Enzymes Co. LTDInventors: Fuping LU, Yihan LIU, Yu LI, Xingji WANG, Kefen WANG, Wenlong LIU, Fufeng LIU, Huitu ZHANG
-
Patent number: 11547130Abstract: The present invention discloses a novel nano-composite antibacterial material and a preparation method and an application thereof, and belongs to the technical field of preservative materials. The novel nano-composite antibacterial material disclosed by the present invention is prepared by mixing a dimethylimidazole solution, deionized water and a zinc nitrate solution to prepare a metal-organic framework carrier, compositing with nisin to form a nano antibacterial composite material, separating out from a solution in a precipitate form, centrifuging, removing a supernatant, cleaning and re-suspending with the deionized water. The novel nano-composite antibacterial material prepared by the present invention has an antibacterial effect superior to nisin having a same concentration.Type: GrantFiled: March 12, 2020Date of Patent: January 10, 2023Assignee: Tianjin University of Science and TechnologyInventors: Shiru Jia, Jiandong Cui, Zhilei Tan, Cheng Zhong, Yang Liu, Qiaozhen Luo, Xiaona Li, Yuxiao Feng, Baoting Sun, Le Zhong
-
Patent number: 11535876Abstract: The present disclosure relates to the field of genetic engineering, especially relates to a xylose-induced genetically engineered bacteria used for producing ectoine as well as a construction method and use thereof. The genetically engineered bacteria is constructed by heterologously expressing the ectABC gene cluster from Halomonas elongata on the E. coli chromosome, using the promoter of xylose transporter coding gene xylF to control the RNA polymerase from T7 bacteriophage, reconstructing a synthesis pathway of ectoine and constructing a plasmid-free system, and enhancing the expression of target genes by a strong promoter T7; the yield of ectoine reached 12-16 g/L after 20-28 h fermentation in shake flask, and reached 35-50 g/L after 24-40 h fermentation in a 5 L fermentor.Type: GrantFiled: June 14, 2017Date of Patent: December 27, 2022Assignee: Tianjin University of Science and TechnologyInventors: Xixian Xie, Xuejiao Wu, Ning Chen, Fangqing Yan, Qian Ma, Jie Ma, Hongchao Zhang
-
Publication number: 20220403348Abstract: A genetically engineered bacterium includes a genome of the Eschericia coli and a mutant encoding gene hisG* of a Corynebacterium glutamicum ATP phosphoribosyl transferase HisG on the genome, and the gene hisG* is strongly expressed to enhance activity of a key enzyme HisG for histidine synthesis. The gene hisG* has a nucleotide sequence as shown in SEQ ID NO: 1; a copy number of histidine operon genes hisDBCHAFI of the Eschericia coli is further increased on the genome to enhance a terminal synthetic route of histidine; an encoding gene lysE from an arginine/lysine transportprotein of the Corynebacterium glutamicum is further integrated to the genome and strongly expressed to promote the intracellular histidine secrete to the extracellular space; and an encoding gene rocG of glutamate dehydrogenase of Bacillus subtilis is further integrated to the genome and strongly expressed to promote generation of histidine.Type: ApplicationFiled: June 18, 2021Publication date: December 22, 2022Applicants: ZHEJIANG ZHENYUAN BIOTECH CO., LTD., Tianjin University of Science and TechnologyInventors: Xixian XIE, Weiming FAN, Heyun WU, Wei JIANG, Daoguang TIAN, Yanna CHEN, Yue ZHANG, Jianqing TU
-
Patent number: 11453898Abstract: The present invention belongs to the bioengineering field, and relates to a method for fermentation production of L-theanine by using an Escherichia coli genetically engineered bacterium. The engineered bacterium is obtained by serving a strain as an original strain, wherein the strain is obtained after performing a single copy of T7RNAP, a dual copy of gmas, xylR knockout, and sucCD knockout on an Escherichia coli W3110 genome, and by integrating genes xfp, pta, acs, gltA, and ppc, and knocking out ackA on the genome. The present invention has a high yield, and stable production performance; after 20-25 h, L-theanine has a titer of 75-80 g/L, and the yield is up to 52-55%. The fermentation broth is purified by membrane separation in combination with a cation-anion resin series technique. Moreover, the one-step crystallization yield is 72.3% and the L-theanine final product has a purity of 99%.Type: GrantFiled: December 31, 2021Date of Patent: September 27, 2022Assignees: Henan Julong Biological Engineering Co., Ltd, Tianjin University of Science and TechnologyInventors: Xiaoguang Fan, Xiaodong Liu, Jing Li, Ning Chen, Bochao Liu, Shuai Liu, Chaochao Sun, Yongchao Liu, Jiajia Teng, Mengtao Zhang, Yuanqing Ji, Yuhang Zhou, Qingyang Xu
-
Patent number: 11447760Abstract: A method of using lactase for generating galactooligosaccharide as well as the preparation and an application of the lactase are provided. Lactase (BglD305 derived from Bacillus circulans B2301 and BglD derived from Bacillus circulans ATCC 31382) molecules from two sources are taken as the basis for molecular evolution, so as to obtain new lactase enzyme molecules with high galactooligosaccharide synthesis efficiency and good expression performance. The high-producing strain lactase is further constructed, the lactase can be efficiently synthesized during the submerged fermentation, and the enzyme molecule is secreted into the culture medium, the high-activity enzyme preparation is directly prepared from the fermentation supernatant, and the lactase expression level can achieve 2208 U/mL. As the result, the fermentation manufacturing cost of lactase is reduced, the fermentation manufacturing process is simplified, and the quality of the lactase preparation is improved.Type: GrantFiled: September 15, 2021Date of Patent: September 20, 2022Assignee: Tianjin University of Science and TechnologyInventors: Zhengxiang Wang, Dandan Niu, Kangming Tian
-
Patent number: 11413281Abstract: Disclosed is a targeted delivery system for a hydrophobic antitumor drug, referring to conjugates of E-selectin polypeptide ligand-polyethylene glycol-antitumor drug connected by different link bridges containing disulfide bonds. The synthesis of the conjugates, antitumor activity evaluation, the particle size and morphology characteristics of nanoparticles self-assembled by the conjugates in an aqueous solution, and the release of the antitumor drug in different conditions are comprised. The conjugates can actively target at vessels of a tumor site by the E-selectin peptide ligand, and can also self-assemble into nanoparticles in an aqueous solution, so as to be passively targeted at the tumor site by EPR effect.Type: GrantFiled: July 21, 2016Date of Patent: August 16, 2022Assignee: TIANJIN UNIVERSITY OF SCIENCE & TECHNOLOGYInventors: Peng Yu, Na Guo, Dong Wang, Yuou Teng, Tiantian Hao, Huan Liu, Tianle Zhang, Xiuzhuan Shang
-
Patent number: 11376553Abstract: A superhydrophobic polypropylene porous film, including a polypropylene porous film substrate, titanium dioxide layers and a surface modifier layer, is disclosed. The titanium dioxide layers are deposited on the surface of the polypropylene porous film substrate by atomic deposition technology; a surface modifier is coated on the titanium dioxide layers; hydrophobic bonds are formed between the titanium dioxide layers and the surface modifier layer; the superhydrophobic polypropylene porous film has a water contact angle greater than 150 degrees, a rolling angle less than 10 degrees, an aperture of 0.1-0.4 ?m, a porosity of 50%-80%, a tensile strength of 30-50 MPa, and an elongation at break of 10%-30%.Type: GrantFiled: November 15, 2021Date of Patent: July 5, 2022Assignee: Tianjin University of Science and TechnologyInventors: Na Tang, Yangyang Song, Lei Zhang, Xingxing Shi, Songbo Wang, Penggao Cheng, Wei Du, Jianping Zhang
-
Patent number: 11365127Abstract: A large-particle spherical salt with a particle size of 400-950 ?m and a sphericity of 0.5-1.0 is disclosed, which overcomes the existing difficulty in this field for larger particle size as well as higher sphericity. A preparation method of the large-particle spherical salt is also disclosed, wherein in one preparation process, 2% of gum arabic (based on the mass percentage of solute sodium chloride in a sodium chloride saturated solution) is added, and under conditions of an evaporating temperature of 60° C. a stirring rate of 350 rpm, and an evaporating time of 8 hours, a large-particle spherical salt with a particle size of 921.593 ?m and an average sphericity of 0.904 is successfully prepared. The large-particle spherical salt prepared by the method has a uniform particle size distribution and good appearance, can be combined with other substances, adding some extra value to the salt. Meanwhile, the large-particle spherical salt prepared by the method has a high safety grade (e.g.Type: GrantFiled: August 15, 2021Date of Patent: June 21, 2022Assignee: TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Na Tang, Min Lu, Wei Du, Penggao Cheng, Jun Xiang, Lei Zhang, Songbo Wang, Jianping Zhang
-
Patent number: 11352633Abstract: An Aureobasidium pullulans recombinant strain with high-yield heavy oil and a construction method and application thereof are provided. The Aureobasidium pullulans recombinant strain is obtained by knocking out a pullulan synthetase PUL gene while overexpressing an ACL gene. The obtained Aureobasidium pullulans recombinant strain can significantly increase the yield of heavy oil. After 7-day fermentation with xylose as carbon source, the yield of the heavy oil of the recombinant strain reaches 19.4372 g/L, while the yield of the heavy oil of the original strain is 10.0325 g/L, i.e. the recombinant strain improves the yield by 93.74% compared with the original strain.Type: GrantFiled: October 15, 2020Date of Patent: June 7, 2022Assignee: Tianjin University of Science and TechnologyInventors: Yefu Chen, Siyao Huang, Peng Zheng, Yuanhua Wang, Jian Guo, Mengjuan Zhang, Xuewu Guo, Dongguang Xiao
-
Patent number: 11339254Abstract: A lignocellulose nanofibril material, a stable foam system based thereon, a preparation method and an application thereof are provided. The lignocellulosic nanofibril material includes the following components: 0.5-20 wt % of wood flour, 0.1-10 wt % of (2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl, 2-25 mmol/g of an oxidant, 6-15 wt % of NaBr, and the remaining is water. The stable foam system based on the lignocellulosic nanofibril material includes: 0.1-1.0 wt % of the lignocellulosic nanofibril material, 0.2-1.0 wt % of a surfactant, 0.1-10 wt % of sodium chloride, 0.1-1.0 wt % of calcium chloride, 0.1-1.0 wt % of magnesium chloride, 0.1-1.0 wt % of sodium sulfate, and a balance of water.Type: GrantFiled: April 15, 2019Date of Patent: May 24, 2022Assignees: SOUTHWEST PETROLEUM UNIVERSITY, TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Bing Wei, Yangbing Wen, Yuanyuan Wang, Wanfen Pu, Shengen Chen
-
Publication number: 20220098563Abstract: A method of using lactase for generating galactooligosaccharide as well as the preparation and an application of the lactase are provided. Lactase (BglD305 derived from Bacillus circulans B2301 and BglD derived from Bacillus circulans ATCC 31382) molecules from two sources are taken as the basis for molecular evolution, so as to obtain new lactase enzyme molecules with high galactooligosaccharide synthesis efficiency and good expression performance. The high-producing strain lactase is further constructed, the lactase can be efficiently synthesized during the submerged fermentation, and the enzyme molecule is secreted into the culture medium, the high-activity enzyme preparation is directly prepared from the fermentation supernatant, and the lactase expression level can achieve 2208 U/mL. As the result, the fermentation manufacturing cost of lactase is reduced, the fermentation manufacturing process is simplified, and the quality of the lactase preparation is improved.Type: ApplicationFiled: September 15, 2021Publication date: March 31, 2022Applicant: Tianjin University of Science and TechnologyInventors: Zhengxiang WANG, Dandan NIU, Kangming TIAN